| Financial Year |
March 31 2023 |
| Monetary Funds |
284,018,636.75 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
508,558,172.34 |
| Advances to Suppliers |
223,512,874.21 |
| Other Receivables |
23,560,961.89 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
549,437,799.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,995,591.27 |
| Total Current Assets |
1,754,741,848.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,006,125,641.43 |
| Under-construction Projects |
8,231,827.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
276,290,400.02 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
21,561,652.27 |
| Other Non-Current Assets |
2,574,841.77 |
| Sub-Total of Non-Current Assets |
1,314,784,363.36 |
| Total Assets |
3,069,526,211.38 |
| Short-Term Loans |
243,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
88,342,587.22 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,120,345.80 |
| Taxes Payable |
25,574,846.39 |
| Interest Payable |
234,842.47 |
| Dividend Payable |
-- |
| Other payables |
66,363,154.67 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
50,135,366.29 |
| Other Current Liabilities |
2,700,888.60 |
| Sub-Total of Current Liabilities |
501,013,255.16 |
| Long-term Loans |
56,928,477.24 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
79,952,228.29 |
| Total Liabilities |
580,965,483.45 |
| Paid-In Capital(Or Share Stock) |
298,731,378.00 |
| Capital Surplus |
865,664,731.41 |
| Surplus Reserve |
186,914,881.92 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,074,747,030.98 |
| Minority Stockholder's Interest |
62,502,705.62 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,426,058,022.31 |
| Owner's Equity（Stockholder's Equity） |
2,488,560,727.93 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,069,526,211.38 |
